Nevirapine
NDC 65862-057, Nevirapine, suspension, from Aurobindo Pharma Limited.
- Product NDC
- 65862-057
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077702
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-057 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEVIRAPINE HEMIHYDRATE50 mg/5mL
Pharmacologic classes
Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-057-11 | 65862005711 | 100 mL in 1 BOTTLE (65862-057-11) |
| 65862-057-24 | 65862005724 | 240 mL in 1 BOTTLE (65862-057-24) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8dfe86aa-ea5d-48d2-94a8-1a5506055d70
Use it
Look up 65862-057 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-057 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-057. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.